溶解性の微小針ががん治療への光の道を開く(Dissolvable, microscopic needles light the way for cancer treatments)

ad

2026-09-18 テキサスA&M大学

テキサスA&M大学とサンパウロ大学の研究チームは、皮膚がんなどに対する光線力学療法(PDT)の効果を高める、溶解性マイクロニードルを開発した。数百本の生体適合性を持つ微小なピラミッド状針をパッチに配置し、皮膚に挿入すると溶解して薬剤を病変内部へ届けると同時に、治療に必要な光を皮膚内部へ導き、均一に分散させる。PDTは光感受性薬剤、光、酸素を利用して活性酸素を発生させ、病変細胞を局所的に破壊するが、皮膚による光の散乱・減衰が課題だった。実験では、マイクロニードルが緑色レーザーを皮膚内部へ導入し、光をより均一に分布させることを確認した。従来の外用クリームに比べ、腫瘍組織内への薬剤分布を深く均一にできることも既報で示されている。研究チームは今後、非黒色腫皮膚がんを対象とした臨床試験を予定している。

溶解性の微小針ががん治療への光の道を開く(Dissolvable, microscopic needles light the way for cancer treatments)
Biomedical researchers at Texas A&M University’s College of Engineering and the University of São Paulo have developed dissolvable microneedles, each only a few times wider than a human hair, that can deliver therapeutic drugs and redistribute light beneath the skin, offering a practically painless, scar-free alternative to invasive surgery and a new path to treating skin cancer and other light-responsive conditions. Credit: Dr. Michelle Requena/Texas A&M University College of Engineering.

<関連情報>

光分布改善による薬剤送達の構成:光線力学療法を用いた皮膚がん治療における溶解性マイクロニードルの使用 Composing drug delivery with light distribution improvement: the use of dissolving microneedles in skin cancer with photodynamic therapy

Michelle B. Requena, Cynthia E. Anderson, Dianeth S. Lima Bejar, Vladislav V. Yakovlev, Vanderlei S. Bagnato
Journal of Biomedical Optica  Published:9 May 2026
DOI:https://doi.org/10.1117/1.JBO.31.5.058001

Abstract

Significance
Dissolving microneedles (MN) have emerged as a promising platform for drug delivery, providing a minimally invasive approach to bypass the skin’s natural barriers and enhance molecular penetration and diffusion. Their biocompatibility, user-friendly application, and ability to deliver precise therapeutic dosing make them particularly suitable for dermatological use. In addition to pharmacological benefits, dissolving MN possesses a geometric structure that enables optical waveguiding, thereby improving light penetration and distribution.

Aim
We address a key limitation of photodynamic therapy (PDT): the limited penetration of light into biological tissues. PDT relies on activating photosensitizing agents with specific wavelengths of light to generate cytotoxic species, selectively targeting abnormal or diseased cells while minimizing effects on surrounding healthy tissue.

Approach
Pyramidal dissolving MN arrays were fabricated from a biocompatible polymer and systematically characterized. Their light distribution profile under laser illumination was evaluated using image analysis.

Results
Quantitative analysis of light distribution demonstrates that MN can simultaneously facilitate drug delivery and light distribution.

Conclusions
This multifunctionality provides a synergistic therapeutic advantage, as localized drug release is complemented by optimized light delivery, thereby enhancing treatment outcomes. The dual-function platform has significant implications for PDT, enabling the design of integrated therapeutic systems that combine chemical and photonic modalities within a single, biodegradable device. Such systems may be particularly advantageous in resource-limited settings or outpatient care, where ease of use and effectiveness are essential. This strategy offers an approach to overcoming the limitations of conventional light-based therapies, supporting the development of more effective and accessible treatments for skin cancer and other dermatological conditions.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました